Bcl-2 proteins in development, health, and disease of the hematopoietic system

The FEBS Journal
Matthias KollekMiriam Erlacher

Abstract

Members of the Bcl-2 protein family regulate cell fate decisions following a variety of developmental cues or stress signals, with the outcomes of cell death or survival, thus shaping multiple mammalian tissues. This review describes in detail how anti- and proapoptotic Bcl-2 proteins contribute to the development and functioning of the fetal and adult hematopoietic systems and how they influence the generation and maintenance of different hematopoietic lineages. An overview on how stress signals such as genotoxic stress or inflammation can compromise blood cell production, partially by engaging the intrinsic apoptosis pathway, is presented. Finally, the review describes how Bcl-2 protein deregulation-either leading to increased apoptosis resistance or excessive cell death-contributes to many hematological disorders, with specific focus on rare disorders of hematopoiesis and how this knowledge may be used therapeutically.

References

Jan 1, 1991·Annual Review of Immunology·P L Cohen, R A Eisenberg
Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A StrasserA W Harris
Jan 1, 1988·Mechanisms of Ageing and Development·M MagnaniG Fornaini
Oct 6, 1995·Science·C M KnudsonS J Korsmeyer
May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·A MaC B Thompson
Jan 1, 1996·Stem Cells·T DemirerW I Bensinger
Feb 7, 1997·Cell·S Nagata
Feb 26, 1998·The New England Journal of Medicine·M SilvaJ L Fernández-Luna
May 15, 1998·British Journal of Haematology·F CalleraR P Falcão
Dec 29, 1998·The Journal of Biological Chemistry·G ChenA Greenberg
Oct 16, 1999·The Journal of Biological Chemistry·M P ScheidV Duronio
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·S OgilvyJ M Adams
Dec 2, 2000·Nature·B B Zhou, S J Elledge
Jul 12, 2002·American Journal of Hematology·Delphine BoudardLydia Campos

❮ Previous
Next ❯

Citations

Jun 15, 2017·BioMedicine·Jai-Sing YangFuu-Jen Tsai
Sep 9, 2017·The Journal of Experimental Medicine·Matthias KollekMiriam Erlacher
Aug 30, 2018·Stem Cells·Sehar AfreenMiriam Erlacher
Aug 24, 2016·Nature Reviews. Rheumatology·Carla M CudaHarris Perlman
Sep 27, 2019·European Journal of Immunology·Jennifer JaufmannSandra Beer-Hammer
May 6, 2020·Investigational New Drugs·Małgorzata Opydo-ChanekLidia Mazur
Jan 16, 2020·Scientific Reports·Lionel RohnerMichaela Fux
Mar 1, 2021·Protein Science : a Publication of the Protein Society·David A PriceSean D Moran

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.